eFFECTOR Therapeutics Revenue

Revenue

n/a

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

Market Cap

2.35K

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	-	-	-
Dec 31, 2022	3.55M	2.12M	148.46%
Dec 31, 2021	1.43M	-40.57M	-96.60%
Dec 31, 2020	42.00M	-	-
Dec 31, 2019	-	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Affimed	6.29M
Hemagen Diagnostics	4.04M
Comera Life Sciences Holdings	1.00M
Endonovo Therapeutics	255.72K
MetaStat	23.30K

Revenue Rankings

eFFECTOR Therapeutics News

1 year ago - BioGene Therapeutics Announces Appointment of Dr. Brian Gallagher, Jr. to Corporate Advisory Board - Newsfile Corp
2 years ago - Twelve option delistings on June 24th - TheFly
2 years ago - eFFECTOR Therapeutics Announces it will Wind Down Operations as it Seeks Strategic Alternatives and Expects to be Delisted from Nasdaq - GlobeNewsWire
2 years ago - eFfector Therapeutics to collaborate with Dana-Farber Cancer Institute - TheFly
2 years ago - eFFECTOR Therapeutics to Collaborate with the Dana-Farber Cancer Institute on an Investigator-Sponsored Phase 2 Clinical Trial Evaluating Zotatifin as Combination Treatment in ER+ Endometrial Cancer and in Low Grade Serous Ovarian Cancer - GlobeNewsWire
2 years ago - eFfector Therapeutics reports Q1 EPS ($2.16), consensus ($2.16) - TheFly
2 years ago - eFFECTOR Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
2 years ago - eFFECTOR Therapeutics to Participate in Upcoming Investor Conference - GlobeNewsWire

More News